Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors

Tyrosine kinase inhibitors (TKIs) have improved the overall survival of patients with gastrointestinal stromal tumors (GISTs), but their side effects can impact dose intensity and, consequently, the clinical benefit. To date, no guideline or consensus has been published on the TKI-associated adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Wang, Ming, Zhang, Bo, Wu, Xin, Lin, Tian-Long, Liu, Xiu-Feng, Zhou, Ye, Zhang, Xin-Hua, Xu, Hao, Shen, Li-Jing, Zou, Jing, Lu, Ping, Zhang, Dong, Gu, Wei-Jun, Zhang, Mei-Xia, Pan, Jian, Cao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295840/
https://www.ncbi.nlm.nih.gov/pubmed/30581268
http://dx.doi.org/10.3748/wjg.v24.i46.5189

Ejemplares similares

Ejemplares similares